Oral Versus Intravenous Magnesium on Emergence Delirium
Recruiting
Phase 2
Phase 3
Interventional Study
Magnesium
Emergence Delirium
Children
Adenotonsillectomy
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 4 – 7
- Sex
- Any
- Trial phase
- Phase 2/3
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 360 (estimated)
- Sponsor
- Tanta University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This prospective randomized controlled study will be conducted to compare the effects of preoperative oral magnesium and intraoperative IV magnesium on the incidence and severity of emergence delirium in children undergoing adenotonsillectomy using sevoflurane anesthesia.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Children aged 4 to 7 years
* American Society of Anesthesiologist (ASA) Status I or II
* Planned for an adenotonsillectomy procedure under sevoflurane general anesthesia.
Exclusion Criteria:
* Parents declined to participate in the trial
* Behavioral changes, neurological or…
Contacts